Qurient Co., Ltd. (KOSDAQ:115180)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Medicine Wholesale and Retail	9.03B	7.88B	4.69B
Medicine Wholesale and Retail Growth	14.66%	68.10%	-
Medicine Research and Development	-	591.72M	200.00M
Medicine Research and Development Growth	-	195.86%	-
Total	9.03B	8.47B	4.89B
Total Growth	6.65%	73.33%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
South Korea	9.03B	8.47B	4.89B
South Korea Growth	6.65%	73.33%	-
Total	9.03B	8.47B	4.89B
Total Growth	6.65%	73.33%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 7, 2026

Data Sources Report a data error